Andrew MacGarvey, CEO, CROS NT06.06.17
There are many reasons why a pharmaceutical company chooses a contract research organization (CRO) for drug development. The selection process is complex and based on several important considerations including: CRO experience, budget, availability of resources, and a trusting relationship between the CRO and sponsor.
Outsourcing strategy in the drug development sector is known for its cyclical changes. Companies move between utilizing project-based outsourcing, in-house teams, functional outsourcing, and strategic partnerships in response to the changing global business climate. The requirement to adapt is not unique to trial Sponsors and we should not be surprised that strategic business models need to change as well.
Let’s take a step back and look at the real “end game” of clinical research.
Over the last few years, trends in the sector have pointed to a strategic model in which CROs are chosen for both their expertise as well as their willingness to invest in the development of a drug. Pharmaceutical companies have realized the strategic advantages of “cost-sharing” and sharing the risks and benefi
Outsourcing strategy in the drug development sector is known for its cyclical changes. Companies move between utilizing project-based outsourcing, in-house teams, functional outsourcing, and strategic partnerships in response to the changing global business climate. The requirement to adapt is not unique to trial Sponsors and we should not be surprised that strategic business models need to change as well.
Let’s take a step back and look at the real “end game” of clinical research.
Over the last few years, trends in the sector have pointed to a strategic model in which CROs are chosen for both their expertise as well as their willingness to invest in the development of a drug. Pharmaceutical companies have realized the strategic advantages of “cost-sharing” and sharing the risks and benefi
Continue reading this story and get 24/7 access to Contract Pharma for FREE
FREE SUBSCRIPTION